Performance of 2 commercial real-time polymerase chain reaction assays for the detection of Aspergillus and Pneumocystis DNA in bronchoalveolar lavage fluid samples from critical care patients

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 2, 2012, Pages 138-143

  Orsi, Carlotta Francesca ^a   Gennari, William ^b   Venturelli, Claudia ^b   La Regina, Annunziata ^b   Pecorari, Monica ^b   Righi, Elena ^a   Machetti, Marco ^c   Blasi, Elisabetta ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^c Arrow Diagnostics Srl   (Italy)

Author keywords

Aspergillus; BAL; Fungal DNA; Pneumocystis; Real time PCR

Indexed keywords

FUNGAL DNA;

ADULT; AGED; ARTICLE; ASPERGILLUS; ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DNA DETERMINATION; FEMALE; HUMAN; INVASIVE ASPERGILLOSIS; LUNG LAVAGE; MALE; PATIENT CODING; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY;

ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; CRITICAL CARE; DNA, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR TYPING; PNEUMOCYSTIS; PNEUMONIA, PNEUMOCYSTIS; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84861196992     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.03.001     Document Type: Article

References (14)

1. Alanio A., Desoubeaux G., Sarfati C., Hamane S., Bergeron A., Azoulay E., et al. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. Clin Microbiol Infect 2011, 17:1531-1537.
2. Cushion M.T. Are members of the fungal genus Pneumocystis (a) commensals; (b) opportunists; (c) pathogens; or (d) all of the above?. PLoS Pathog 2010, 23:e1001009.
3. Hauser P.M., Bille J., Lass-Florl C., Geltner C., Feldmesser M., Levi M., et al. Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay. J Clin Microbiol 2011, 49:1872-1878.
4. Hope W.W., Walsh T.J., Denning D.W. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005, 5:609-622.
5. Kontoyiannis D.P., Bodey G.P. Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 2002, 21:161-172.
6. Marr K.A., Carter R.A., Boeckh M., Martin P., Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002, 100:4358-4366.
7. Matsumura Y., Ito Y., Iinuma Y., Yasuma K., Yamamoto M., Matsushima A., et al. Quantitative real-time PCR and the (1->3)-beta-d-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization. Clin Microbiol Infect 2011, [Epub ahead of print]. 10.1111/j.1469-0691.2011.03605.x.
8. Meersseman W., Lagrou K., Maertens J., Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007, 45:205-216.
9. Pulvirenti J., Herrera P., Venkataraman P., Ahmed N. Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era. AIDS Patient Care STDS 2003, 17:261-265.
10. Roblot F., Godet C., Le Moal G., Garo B., Faouzi Souala M., Dary M., et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis 2002, 21:523-531.
11. Sing A., Trebesius K., Roggenkamp A., Russmann H., Tybus K., Pfaff F., et al. Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups. J Clin Microbiol 2000, 38:1461-1467.
12. Torelli R., Sanguinetti M., Moody A., Pagano L., Caira M., De Carolis E., et al. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 2011, 49:4273-4278.
13. White P.L., Perry M.D., Moody A., Follett S.A., Morgan G., Barnes R.A. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis. J Clin Microbiol 2011, 49:2169-2174.
14. Yeo S.F., Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002, 15:465-484.